Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker

[1]  S. Han,et al.  Molecular assessment of artemisinin resistance markers, polymorphisms in the k13 propeller, and a multidrug-resistance gene in the eastern and western border areas of Myanmar. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  Gilean McVean,et al.  Genetic architecture of artemisinin-resistant Plasmodium falciparum , 2015, Nature Genetics.

[3]  Steve M. Taylor,et al.  Absence of putative artemisinin resistance mutations among Plasmodium falciparum in Sub-Saharan Africa: a molecular epidemiologic study. , 2015, The Journal of infectious diseases.

[4]  John C. Tan,et al.  Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia. , 2015, The Journal of infectious diseases.

[5]  D. Kwiatkowski,et al.  Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance , 2015, Science.

[6]  D. Fidock,et al.  K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates , 2015, Science.

[7]  D. Kwiatkowski,et al.  K13-Propeller Polymorphisms in Plasmodium falciparum Parasites From Sub-Saharan Africa , 2014, The Journal of infectious diseases.

[8]  B. Pradines,et al.  Limited polymorphisms in k13 gene in Plasmodium falciparum isolates from Dakar, Senegal in 2012–2013 , 2014, Malaria Journal.

[9]  R. Haque,et al.  Mutations in Plasmodium falciparum K13 propeller gene from Bangladesh (2009–2013) , 2014, Malaria Journal.

[10]  N. Lucchi,et al.  Efficacy of Artemether-Lumefantrine and Dihydroartemisinin-1 Piperaquine for the Treatment of Uncomplicated Malaria in Children 2 in Zaire and Uíge Provinces , Angola 3 4 , 2014 .

[11]  A. Rosanas-Urgell,et al.  Delayed Parasite Clearance after Treatment with Dihydroartemisinin-Piperaquine in Plasmodium falciparum Malaria Patients in Central Vietnam , 2014, Antimicrobial Agents and Chemotherapy.

[12]  P. Rosenthal,et al.  Polymorphisms in K13 and Falcipain-2 Associated with Artemisinin Resistance Are Not Prevalent in Plasmodium falciparum Isolated from Ugandan Children , 2014, PloS one.

[13]  D. Ménard,et al.  Molecular surveillance for artemisinin resistance in Africa. , 2014, The Lancet. Infectious diseases.

[14]  C. MacPherson,et al.  Genome editing in the human malaria parasite Plasmodium falciparum using the CRISPR-Cas9 system , 2014, Nature Biotechnology.

[15]  D. Saunders,et al.  Dihydroartemisinin-piperaquine failure in Cambodia. , 2014, The New England journal of medicine.

[16]  D. Kwiatkowski,et al.  Spread of artemisinin resistance in Plasmodium falciparum malaria. , 2014, The New England journal of medicine.

[17]  N. Mishra,et al.  Declining efficacy of artesunate plus sulphadoxine-pyrimethamine in northeastern India , 2014, Malaria Journal.

[18]  N. Khim,et al.  Artemisinin resistance in Plasmodium falciparum. , 2014, The Lancet. Infectious diseases.

[19]  N. Khim,et al.  Plasmodium falciparum Founder Populations in Western Cambodia Have Reduced Artemisinin Sensitivity In Vitro , 2014, Antimicrobial Agents and Chemotherapy.

[20]  B. Genton,et al.  A molecular marker of artemisinin-resistant Plasmodium falciparum malaria , 2013, Nature.

[21]  Anand P. Patil,et al.  Spatiotemporal mathematical modelling of mutations of the dhps gene in African Plasmodium falciparum , 2013, Malaria Journal.

[22]  Gilean McVean,et al.  Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia , 2013, Nature Genetics.

[23]  J. Perin,et al.  Reduced Susceptibility of Plasmodium falciparum to Artesunate in Southern Myanmar , 2013, PloS one.

[24]  F. Nosten,et al.  Malaria Burden and Artemisinin Resistance in the Mobile and Migrant Population on the Thai–Myanmar Border, 1999–2011: An Observational Study , 2013, PLoS medicine.

[25]  C. Wongsrichanalai,et al.  Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010. , 2013, The Southeast Asian journal of tropical medicine and public health.

[26]  R. Haque,et al.  Current Status of Artemisinin-Resistant falciparum Malaria in South Asia: A Randomized Controlled Artesunate Monotherapy Trial in Bangladesh , 2012, PloS one.

[27]  Saorin Kim,et al.  Reduced Artemisinin Susceptibility of Plasmodium falciparum Ring Stages in Western Cambodia , 2012, Antimicrobial Agents and Chemotherapy.

[28]  D. Ménard,et al.  Efficacy of Dihydroartemisinin-Piperaquine for Treatment of Uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, 2008 to 2010 , 2012, Antimicrobial Agents and Chemotherapy.

[29]  F. Nosten,et al.  Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study , 2012, The Lancet.

[30]  David L. Smith,et al.  A new world malaria map: Plasmodium falciparum endemicity in 2010 , 2011, Malaria Journal.

[31]  Richard J. Maude,et al.  Intrahost modeling of artemisinin resistance in Plasmodium falciparum , 2010, Proceedings of the National Academy of Sciences.

[32]  N. White.  Artemisinin resistance—the clock is ticking , 2010, The Lancet.

[33]  Anand P. Patil,et al.  Estimating the Global Clinical Burden of Plasmodium falciparum Malaria in 2007 , 2010, PLoS medicine.

[34]  T. Wellems,et al.  The impact of malaria parasitism: from corpuscles to communities. , 2009, The Journal of clinical investigation.

[35]  K. Silamut,et al.  Artemisinin resistance in Plasmodium falciparum malaria. , 2009, The New England journal of medicine.

[36]  David L. Smith,et al.  A World Malaria Map: Plasmodium falciparum Endemicity in 2007 , 2009, PLoS medicine.

[37]  Stephane Proux,et al.  Changes in the Treatment Responses to Artesunate-Mefloquine on the Northwestern Border of Thailand during 13 Years of Continuous Deployment , 2009, PloS one.

[38]  C. Wongsrichanalai,et al.  Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia , 2009, Malaria Journal.

[39]  M. Fukuda,et al.  Evidence of artemisinin-resistant malaria in western Cambodia. , 2008, The New England journal of medicine.

[40]  J. Plotkin,et al.  The Population Genetics of dN/dS , 2008, PLoS genetics.

[41]  P. Ringwald,et al.  Surveillance of the efficacy of artesunate and mefloquine combination for the treatment of uncomplicated falciparum malaria in Cambodia , 2006, Tropical medicine & international health : TM & IH.

[42]  T. Anderson,et al.  The origins and spread of antimalarial drug resistance: lessons for policy makers. , 2005, Acta tropica.

[43]  Nicholas J White,et al.  Antimalarial drug resistance. , 2004, The Journal of clinical investigation.

[44]  G. Matheron.  Principles of geostatistics , 1963 .